Klinik für Kardiologie

Originalarbeiten (Auswahl, nur Erst- oder Letztautor):

1. Schulz E, Tsilimingas N, Rinze R, Reiter B, Wendt M, Oelze M, Woelken-Weckmuller S, Walter U, Reichenspurner H, Meinertz T, Munzel T. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation. 2002 Mar 12; 105(10): 1170-5. (IF 17,0)

2. Schulz E, Anter E, Zou MH, Keaney JF Jr. Estradiol-mediated endothelial nitric oxide synthase association with heat shock protein 90 requires adenosine monophosphate-dependent protein kinase. Circulation. 2005 Jun 28;111(25):3473-80. (IF 17,0)

3. Wenzel P*, Schulz E*, Oelze M, Müller J, Schuhmacher S, Alhamdani MS, Debrezion J, Hortmann M, Reifenberg K, Fleming I, Münzel T, Daiber A. AT(1)-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats. Free Radic Biol Med. 2008 May 23. *gleichberechtigte Erstautoren (IF 5,8)

4. Schulz E, Dopheide J, Schuhmacher S, Thomas SR, Chen K, Daiber A, Wenzel P, Münzel T, Keaney JF Jr. Suppression of the JNK Pathway by Induction of a Metabolic Stress Response Prevents Vascular Injury and Dysfunction. Circulation. Sep 23;118(13):1347-57. (IF 17,0)

5. Wenzel P*, Schulz E*, Gori T, Ostad MA, Mäthner F, Schildknecht S, Göbel S, Oelze M, Stalleicken D, Warnholtz A, Münzel T, Daiber A. Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: implications for nitrate therapy in humans. J Pharmacol Exp Ther. 2009 Jul;330(1):63-71. *shared first authorship (IF 3,8)

6. Schuhmacher S*, Schulz E*, Oelze M, König A, Roegler C, Lange K, Sydow L, Kawamoto T, Wenzel P, Münzel T, Lehmann J, Daiber A. A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena. Br J Pharmacol. 2009 Jun 25. *shared first authorship (IF 5,2)

7. Kröller-Schön S*, Schulz E*, Wenzel P, Kleschyov AL, Hortmann M, Torzewski M, Oelze M, Renné T, Daiber A, Münzel T. Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress. Basic Res Cardiol. 2011 Nov;106(6):1147-58. *shared first authorship (IF 6,0)

8. Schuhmacher S, Foretz M, Knorr M, Jansen T, Hortmann M, Wenzel P, Oelze M, Kleschyov AL, Daiber A, Keaney JF Jr, Wegener G, Lackner K, Münzel T, Viollet B, Schulz E. α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation. Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):560-6. (IF 6,0)

9. Kröller-Schön S, Jansen T, Hauptmann F, Schüler A, Heeren T, Hausding M, Oelze M, Viollet B, Keaney JF Jr, Wenzel P, Daiber A, Münzel T, Schulz E. a1AMP activated protein kinase mediates the vascular protective effects of exercise. Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1632-41. doi: 10.1161/ATVBAHA.111.243980. Epub 2012 Apr 26. (IF 6,0)

10. Kröller-Schön S, Jansen T, Schüler A, Oelze M, Wenzel P, Hausding M, Kerahrodi JG, Beisele M, Lackner KJ, Daiber A, Münzel T, Schulz E. Peroxisome Proliferator-activated Receptor γ, Coactivator 1α Deletion Induces Angiotensin II-Associated Vascular Dysfunction by Increasing Mitochondrial Oxidative Stress and Vascular Inflammation. Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1928-1935. Epub 2013 Jun 20. (IF 6,0)

11. Schulz E, Jabs A, Gori T, Hink U, Sotiriou E, Tschöpe C, Schultheiss HP, Münzel T, Wenzel P. Feasibility and safety of left ventricular endomyocardial biopsy via transradial access: Technique and initial experience. Catheter Cardiovasc Interv. 2015 Oct;86(4):761-5. doi: 10.1002/ccd.25834. Epub 2015 Feb 3. (IF 2,2)

12. Schulz E, Jabs A, Gori T, von Bardeleben S, Hink U, Kasper-König W, Vahl CF, Münzel T. Transcatheter aortic valve implantation with the new-generation Evolut R™: Comparison with CoreValve® in a single center cohort. Int J Cardiol Heart Vasc. 2016 Jul 5;12:52-56. doi: 10.1016/j.ijcha.2016.06.002. eCollection 2016 Sep. (IF -, open access)

13. Schulz E, Jabs A, Tamm A, Herz P, Schulz A, Gori T, von Bardeleben S, Kasper-König W, Hink U, Vahl CF, Münzel T. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort. Int J Cardiol. 2017 Apr 1;232:186-191. doi: 10.1016/j.ijcard.2017.01.032. Epub 2017 Jan 7. (IF 6,2)

     

14. Jansen T, Kröller-Schön S, Schönfelder T, Foretz M, Viollet B, Daiber A, Oelze M, Brandt M, Steven S, Kvandová M, Kalinovic S, Lagrange J, Keaney JF Jr, Münzel T, Wenzel P, Schulz E. α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction. Cardiovasc Res. 2018 Dec 1;114(14):1883-1893. doi: 10.1093/cvr/cvy172. (IF 6,3)  
    
          
15. Kröller-Schön S, Jansen T, Tran TLP, Kvandová M, Kalinovic S, Oelze M, Keaney JF Jr, Foretz M, Viollet B, Daiber A, Kossmann S, Lagrange J, Frenis K, Wenzel P, Münzel T, Schulz E. Endothelial α1AMPK modulates angiotensin II-mediated vascular inflammation and dysfunction. Basic Res Cardiol. 2019 Jan 14;114(2):8. doi: 10.1007/s00395-019-0717-2. (IF 5,7) 

Reviews / Editorials / Case Reports:

1. Schulz E & Keaney JF Jr. Diabetes mellitus and endothelial dysfunction: a central role for oxidative stress. Current Opinion in Endocrinology & Diabetes. 10(4):237-244, August 2003. Review. (IF 3,1)

2. Schulz E, Anter E, Keaney JF Jr. Oxidative stress, antioxidants, and endothelial function. Curr Med Chem. 2004 May;11(9):1093-104. Review. (IF 3,1)

3. Münzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med. 2008;40(3):180-96. Review. (IF 2,6)

4. Schulz E, Jansen T, Wenzel P, Daiber A, Münzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal. 2008 Jun;10(6):1115-26. Review. (IF 7,1)

5. Schulz E, Münzel T. NOX5, a new "radical" player in human atherosclerosis? J Am Coll Cardiol. 2008 Nov 25;52(22):1810-2. Editorial. (IF 17,7)

6. Schulz E, Schuhmacher S, Münzel T. When metabolism rules perfusion: AMPK-mediated endothelial nitric oxide synthase activation. Circ Res. 2009 Feb 27;104(4):422-4. Editorial. (IF 11,5)

7. Wenzel P, Schulz E, Münzel T. Protein Kinase C-Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference. Hypertension. 2009 Oct;54(4):707-9. Editorial. (IF 4,9)

8. Schulz E, Schuhmacher S, Münzel T. Selektive Herzfrequenzreduktion mit Ivabradin bei der stabilen koronaren Herzerkrankung. Der Kardiologe 2009, [Suppl 1], 3: 14-20. Review. (IF 0,1)

9. Münzel T, Schulz E. [Treatment of coronary heart disease with nitric oxide donors]. Pharm Unserer Zeit. 2010 Sep;39(5):359-68. Review. (IF -)

10. Schulz E, Gori T, Münzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 2011 Jun;34(6):665-73. Epub 2011 Apr 21. Review. (IF 3,2)

11. Schulz E, Münzel T. Intracellular pH: a fundamental modulator of vascular function. Circulation. 2011 Oct 25;124(17):1806-7. Editorial. (IF 17,0)

12. Schulz E, Wenzel P, Münzel T, Daiber A. Mitochondrial Redox Signaling: Interaction of Mitochondrial Reactive Oxygen Species with Other Sources of Oxidative Stress. Antioxid Redox Signal. 2012 Jul 13. [Epub ahead of print]. Review. (IF 7,1)

13. Schulz E, Steven S, Münzel T. Is at least one vitamin helping our vasculature? Evidence for an important role of the endothelial vitamin d receptor in regulating endothelial function and blood pressure. Hypertension. 2014 Dec;64(6):1187-8. doi:10.1161/HYPERTENSIONAHA.114.04118. Epub 2014 Sep 8. (IF 4,9)

14. Schulz E, Münzel T. Lumen Size Matters: Role of Protein Disulfide Isomerase A1 in Vascular Remodeling. Hypertension. 2016 Mar;67(3):488-9. doi: 10.1161/HYPERTENSIONAHA.115.06296. Epub 2016 Jan 18. Editorial (IF 4,9)

15. Münzel T, Knorr M, Schmidt F, von Bardeleben S, Gori T, Schulz E. Airborne disease: a case of a Takotsubo cardiomyopathie as a consequence of nighttime aircraft noise exposure. Eur Heart J. 2016 Jul 19. pii: ehw314. (IF 15,1)

16. Stephan von Bardeleben R, Tamm A, Emrich T, Münzel T, Schulz E. Percutaneous transvenous direct annuloplasty of a human tricuspid valve using the Valtech Cardioband. Eur Heart J. 2017 Mar 1;38(9):690. doi: 10.1093/eurheartj/ehw399. Case Report (IF 20,2)

17. Stephan von Bardeleben R, Kasper-König W, Sotiriou E, Beiras-Fernandez A, Friedrich Vahl C, Münzel T, Schulz E. Transcatheter transapical left ventricle remodelling in ischaemic cardiomyopathy with apical aneurysm using 3rd generation 3D cardiac computed tomography fusion imaging. Eur Heart J. 2017 Aug 7;38(30):2378. doi: 10.1093/eurheartj/ehx256. Case Report (IF 20,2)

18. Schulz E, Tamm A, Kasper-König W, Beiras-Fernandez A, Vahl CF, Münzel T, von Bardeleben RS. Transapical implantation of a transcatheter aortic valve prosthesis into a mitral annuloplasty ring guided by real-time three-dimensional cardiac computed tomography-fluoroscopy fusion imaging. Eur Heart J. 2017 Jun 12. doi: 10.1093/eurheartj/ehx296. Case Report (IF 20,2)

19. Schulz E, Beiras-Fernandez A, Rohsbach U, von Bardeleben RS, Sotiriou E, Tamm A, Vahl CF, Münzel T. Successful transcatheter aortic valve-in-valve implantation in a patient having a chronic type A aortic dissection. Eur Heart J. 2017, ehx461, https://doi.org/10.1093/eurheartj/ehx461. Case Report (IF 20,2)

Buchbeiträge:

1. Bedeutung der Herzfrequenz in der Therapie kardiovaskulärer Erkrankungen. Kapitel 4, UNI-MED, 1. Auflage 2008, 72 Seiten, Hardcover, ISBN 978-3-8374-2024-1
2. DGIM Innere Medizin, herausgegeben von Hendrik Lehnert; Kapitel “Akutes Koronarsyndrom”, ISBN: 978-3-642-54676-1 (Online) DOI 10.1007/978-3-642-54676-1; 2016